Incretin-based therapies: a clinical need filled by unique metabolic effects.
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada.
Daniel J
DJ
Drucker
D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D052216:Glucagon-Like Peptide 1 / Q000502:physiology*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D015994:Incidence; D014481:United States
D001786:Blood Glucose; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin